遗传性视网膜疾病的干细胞疗法:系统性审查和元分析
Xiaodong Chen1,2,3, Ningda Xu1,2,3, Jiarui Li1,2,3
1Department of Ophthalmology, Peking University People's Hospital, Eye Diseases and Optometry Institute, Beijing, China.
Stem cell research & therapy
|October 5, 2023
概括
干细胞治疗对视网膜色素炎 (RP) 和Stargardt病 (STGD) 等遗传性视网膜疾病显示出前景,短期内改善视力. 对RP患者的长期益处可能是有限的,需要进一步研究.
科学领域:
- 眼科医生 眼科 眼科
- 再生医学是一种再生医学.
- 遗传学 是一个遗传学.
背景情况:
- 遗传性视网膜疾病 (IRD) 是视力丧失的重要原因之一.
- 干细胞疗法为IRD提供了潜在的再生方法,例如视网膜色素炎 (RP) 和Stargardt病 (STGD).
结论:
- 干细胞疗法在治疗RP和STGD方面似乎是有效和安全的,具有显著的短期视觉效益.
- 在RP患者中,长期视力改善可能不那么明显.
- 进一步的大规模随机临床试验是必要的,以证实这些发现,由于目前的证据低级.
相关概念视频
iPS Cell Differentiation
2.7K
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
2.7K
Stem Cell Therapy for Tissue Regeneration
4.1K
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
4.1K


